A higher dose of anti-T-lymphocyte globulin (ATLG) significantly outperformed a lower dose in preventing graft-vs-host ...
McKeesport-area residents like Patrick McBride don't just anticipate a diagnosis, they brace for exhaustion. When illness ...
Explore the evolving landscape of myeloma treatment, focusing on maintenance therapies and patient experiences with ...
A large, multidisciplinary team led by researchers from Texas A&M University has made a potentially game-changing discovery ...
Ongoing phase 3 trials target improved therapies for hematologic malignancies, focusing on CLL, multiple myeloma, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results